Assessing the Impact of the Low-FODMAP Diet on IBS Management in Asian Countries: A Systematic Review and Meta-Analysis of Evidence
摘要
Irritable bowel syndrome (IBS) is a multifactorial disease which is believed to have a complex pathogenesis unknown till date. IBS is considered chronic condition that can lower the quality of life of a patient. Diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is considered to be a potential therapeutic treatment to improve the symptoms of IBS.
MethodologyA systematic literature search and meta-analysis was conducted to explore the effect of low-FODMAP diet in IBS patients of Asia. The search was conducted through PubMed, Cochrane library, Embase, and Google Scholar.
ResultsThe literature search after careful screening yielded 291 results. Out of these, only 6 were included for the meta- analysis. Post-intervention scores for symptom severity was notably lower in group following low-FODMAP diet.
ConclusionThe meta-analysis provided us with the evidence with an improvement in symptom severity of patients who followed low-FODMAP diet as compared to those who followed traditional or general dietary advice. The study also emphasized on the need for more rigorous and long-term trials for low-FODMAP diet in Asia to determine its efficacy on a larger scale.